Koji Nishida Selected Research

Koji Nishida Research Topics

Disease

6	Infections 11/2020 - 06/2004
4	Neoplasms (Cancer) 12/2018 - 03/2007
4	Wounds and Injuries (Trauma) 12/2018 - 10/2005
4	Spinal Cord Injuries (Spinal Cord Injury) 10/2016 - 08/2006
3	COVID-19 03/2022 - 11/2020
2	Fibrosis (Cirrhosis) 01/2020 - 05/2017
2	Cicatrix (Scar) 05/2017 - 10/2016
2	Thrombosis (Thrombus) 02/2017 - 09/2013
1	Chronic Disease (Chronic Diseases) 06/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2022
1	Lymphopenia (Lymphocytopenia) 06/2022
1	Coinfection 03/2022
1	Right Ventricular Dysfunction 03/2022
1	Myocarditis (Carditis) 03/2022
1	Edema (Dropsy) 03/2022
1	Amyloidosis 10/2021
1	Frailty 10/2021
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 03/2021
1	Thrombocytopenia (Thrombopenia) 11/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Chronic Hepatitis C 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Acute Coronary Syndrome 12/2018
1	Shock 12/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018
1	Multiple Organ Failure (MODS) 12/2018
1	Lymphoma (Lymphomas) 12/2018
1	Atherosclerotic Plaque (Atheroma) 07/2017
1	Gliosis 10/2016
1	Inflammation (Inflammations) 10/2016
1	Adenocarcinoma of Lung 11/2012
1	Adenocarcinoma 11/2012
1	Spinal Cord Diseases 05/2007
1	Mycoses (Diseases, Fungus) 06/2004
1	Keratitis 06/2004
1	Bacterial Infections (Bacterial Infection) 06/2004
1	Ganglion Cysts (Ganglion) 05/2003
1	Corneal Opacity 04/2003
1	Stargardt Disease 09/2002

Drug/Important Bio-Agent (IBA)

2	Rituximab (Mabthera)FDA Link 06/2022 - 12/2018
2	SteroidsIBA 01/2020 - 06/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2018 - 01/2018
1	Bendamustine Hydrochloride FDA Link 06/2022
1	RNA (Ribonucleic Acid)IBA 06/2022
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	Prealbumin (Transthyretin)IBA 10/2021
1	Viral RNAIBA 03/2021
1	AerosolsIBA 11/2020
1	argatroban (MPQA)FDA Link 11/2020
1	Heparin (Liquaemin)FDA LinkGeneric 11/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Ribavirin (Virazole)FDA LinkGeneric 01/2020
1	InterferonsIBA 01/2020
1	SofosbuvirIBA 01/2020
1	ledipasvirIBA 01/2020
1	CarbohydratesIBA 01/2020
1	AntigensIBA 01/2020
1	GadoliniumIBA 05/2017
1	Nerve Growth Factor (NGF)IBA 10/2016
1	neurotrophin 4IBA 10/2016
1	Peptides (Polypeptides)IBA 10/2016
1	Phosphotransferases (Kinase)IBA 10/2016
1	TropomyosinIBA 10/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2016
1	SPG-178IBA 10/2016
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 10/2016
1	CalciumIBA 09/2013
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2012
1	Therapeutic UsesIBA 05/2011
1	1- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimideIBA 05/2007
1	SynaptophysinIBA 03/2007
1	Phosphopyruvate Hydratase (Enolase)IBA 03/2007
1	Fluorometholone (FML)FDA Link 06/2004
1	DNA (Deoxyribonucleic Acid)IBA 06/2004
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2004
1	Messenger RNA (mRNA)IBA 05/2003
1	Adenosine Triphosphate (ATP)IBA 09/2002
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 09/2002

Therapy/Procedure

4	Transplantation 10/2007 - 06/2004
3	Therapeutics 06/2022 - 06/2004
2	Drug Therapy (Chemotherapy) 06/2022 - 12/2018
2	Percutaneous Coronary Intervention 12/2018 - 07/2017
2	Spinal Fusion (Spondylosyndesis) 12/2018 - 01/2018
2	Stents 02/2017 - 09/2013
1	Artificial Respiration (Mechanical Ventilation) 03/2022
1	Radiotherapy 11/2012
1	Corneal Transplantation (Keratoplasty) 06/2004
1	Slit Lamp 04/2003
1	Excimer Lasers 04/2003
1	Keratectomy 04/2003